Elemental Analysis in Organic Synthesis and API Impurity Characterization

In pharmaceutical industries and research areas, the characterization of newly synthesized molecules is a critical step. 

The synthetic intermediate, active pharmaceutical ingredient (API), degradation product, or reference standard—all these products require confirmation of both the molecular structure and elemental composition.

In this article, we will learn about the significance of elemental analysis in organic chemistry and API impurity characterization. Commonly, the elemental analysis is referred to as CHN analysis.

Keywords: Elemental Analysis, CHN Analysis, CHNS Analysis, Pharmaceutical Analytical Techniques, Pharmaceutical Impurity Characterization.

Understanding the New Drug Application (NDA) Process: The Critical Role of Pharmaceutical Impurity Synthesis Companies

To bring a new drug to market is a complex and highly regulated process. 

Before a medicine becomes ready to use for the patients, it undergoes an extensive research, testing, and regulatory evaluation process.

This is to ensure the safety, efficacy, and quality of the drug. 

In this context, one of the most important milestones in this journey is the New Drug Application (NDA) submission.

What Are Statin Drugs? Types, Benefits, and Their Role in Modern Healthcare

High cholesterol is one of the major risk factors contributing to heart attacks, strokes, and other cardiovascular complications. Hence, cardiovascular diseases remain the leading cause of death worldwide. Over the past four decades, statin drugs have become one of the most successful classes of medicines for reducing cholesterol levels and preventing cardiovascular disease.

This article explores statin drugs, their benefits, types, and real-world applications. Additionally, we will focus on the important role played by pharmaceutical impurity synthesis and reference standard manufacturers in supporting ongoing statin research.